Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro
- 1 July 1998
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 41 (4) , 875-882
- https://doi.org/10.1016/s0360-3016(98)00105-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Preclinical studies of chemotherapy and radiation therapy for pancreatic carcinomaCancer, 1996
- Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidineInternational Journal of Radiation Oncology*Biology*Physics, 1996
- A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neckAnnals of Oncology, 1994
- Clinical and preclinical activity of 2′,2′- difluorodeoxycytidine (gemcitabine)Cancer Treatment Reviews, 1993
- Modulation of deoxycytidylate deaminase in intact human leukemia cells: Action of 2',2'-difluorodeoxycytidineBiochemical Pharmacology, 1992
- 2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductaseJournal of Medicinal Chemistry, 1991
- A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.Journal of Clinical Oncology, 1991
- Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cellsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2'-difluoro-D-ribofuranosyl nucleosidesThe Journal of Organic Chemistry, 1988
- Radiation-induced Potentially Lethal Damage: DNA Lesions Susceptible to FixationInternational Journal of Radiation Biology, 1988